XM không cung cấp dịch vụ cho cư dân của Mỹ.

U.S. Costco Wholesale, McKesson, Starbucks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks</title></head><body>

Sept 24 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Costco Wholesale, McKesson and Starbucks, on Tuesday.


HIGHLIGHTS

* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880

* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform

* McKesson Corp MCK.N: Baird cuts target price to $531 from $603

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1,077 from $1,175

* Starbucks SBUX.O: Jefferies cuts to underperform from hold

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.


* Acuity Brands Inc AYI.N: Wells Fargo raises target price to $289 from $260

* Affirm Holdings, Inc. AFRM.O: Barclays raises target price to $54 from $50

* Apellis Pharmaceuticals Inc APLS.O: Wells Fargo cuts target price to $43 from $47

* Axos Financial Inc AX.N: Wedbush cuts target price to $75 from $80

* Banc of California Inc BANC.N: Wedbush raises target price to $18 from $14

* Banc of California Inc BANC.N: Wedbush raises to outperform from neutral

* Bankunited Inc BKU.N: Wedbush raises target price to $40 from $39

* Biohaven Ltd BHVN.N: Bernstein raises target price to $66 from $55

* Biohaven Ltd BHVN.N: Jefferies raises target price to $64 from $57

* Biohaven Ltd BHVN.N: RBC raises target price to $68 from $59

* Black Diamond Therapeutics BDTX.O: Piper Sandler raises target price to $15 from $12

* Black Diamond Therapeutics Inc BDTX.O: Stifel raises target price to $18 from $15

* BP BP.N: Jefferies cuts target price to $40.1 from $43.8

* Braze Inc BRZE.O: Canaccord Genuity cuts target price to $45 from $53

* Braze Inc BRZE.O: D.A. Davidson cuts target price to $55 from $65

* Braze Inc BRZE.O: Oppenheimer cuts target price to $51 from $60

* Braze Inc BRZE.O: TD Cowen cuts target price to $45 from $52

* Bread Financial Holdings Inc BFH.N: Jefferies cuts target price to $50 from $55

* Celsius Holdings Inc CELH.O: Piper Sandler cuts target price to $47 from $50

* CF Industries Holdings Inc CF.N: Wells Fargo raises target price to $92 from $88

* Charles Schwab SCHW.N: Deutsche Bank cuts target price to $77 from $88

* Church & Dwight Co Inc CHD.N: Piper Sandler initiates with overweight rating; PT $120

* Church & Dwight Co., Inc. CHD.N: Wells Fargo raises target price to $113 from $108

* Cibus Inc CBUS.O: Alliance Global Partners cuts target price to $23.50 from $25

* Cogent Biosciences Inc COGT.O: Citigroup raises target price to $15 from $13

* Colgate-Palmolive Co CL.N: Piper Sandler initiates with overweight rating; target $121

* Columbia Banking System Inc COLB.O: Wedbush raises target price to $31 from $28

* Columbia Banking System Inc COLB.O: Wedbush raises to outperform from neutral

* Comerica Inc CMA.N: Wedbush adds stock to its best ideas list

* Comerica Inc CMA.N: Wedbush raises target price to $75 from $52

* Comerica Inc CMA.N: Wedbush raises to outperform from neutral

* Compass Inc. COMP.N: Oppenheimer raises target price to $8 from $6

* Conagra Brands Inc CAG.N: Jefferies raises target price to $30 from $27

* Constellation Brands Inc STZ.N: Barclays raises target price to $309 from $295

* Constellation Energy CEG.O: Barclays raises target price to $280 from $211

* Constellation Energy Corp CEG.O: BMO raises target price to $278 from $246

* Constellation Energy Corp CEG.O: UBS raises target price to $307 from $230

* Corbus Pharmaceuticals Holdings Inc CRBP.O: Mizuho cuts target price to $42 from $74

* Corning GLW.N: Mizuho raises target price to $51 from $47

* Costco Wholesale Corp COST.O: Raymond James raises target price to $980 from $880

* Costco Wholesale Corp COST.O: Truist Securities cuts to hold from buy

* Coty Inc. COTY.N: Wells Fargo cuts target price to $10 from $11

* Crowdstrike CRWD.O: Jefferies raises target price to $345 from $315

* Cullen/Frost Bankers Inc CFR.N: Wedbush cuts target price to $123 from $124

* Customers Bancorp Inc CUBI.N: Wedbush cuts target price to $53 from $79

* Customers Bancorp Inc CUBI.N: Wedbush cuts to neutral from outperform

* CVB Financial Corp CVBF.O: Wedbush cuts target price to $20 from $21

* Dayforce Inc DAY.N: Keybanc initiates coverage with overweight rating;PT $70

* Doordash DASH.O: Raymond James resumes coverage with outperform rating; target $155

* Doubleverify Holdings Inc DV.N: RBC cuts target price to $27 from $33

* Edgewell Personal Care Company EPC.N: Wells Fargo cuts target price to $41 from $43

* EOG Resources Inc EOG.N: JP Morgan raises target price to $139 from $135

* Equinix Inc EQIX.O: CFRA cuts to hold from buy

* Equity Residential EQR.N: BofA Global Research raises price objective to $82 from $78

* Essex Property Trust Inc ESS.N: BofA Global Research raises price objective to $321 from $307

* Fibrobiologics Inc FBLG.O: Maxim Group initiates coverage with buy rating; target price $12

* First Citizens Bancshares FCNCA.O: Wedbush cuts target price to $2150 from $2450

* First Citizens Bancshares FCNCA.O: Wedbush cuts to neutral from outperform

* First Citizens Bancshares FCNCA.O: Wedbush removes stock from its best ideas list

* First Horizon Corp FHN.N: Wedbush cuts target price to $17 from $20

* First Horizon Corp FHN.N: Wedbush cuts to neutral from outperform

* First Horizon Corp FHN.N: Wedbush removes stock from its best ideas list

* Foghorn Therapeutics FHTX.O: Morgan Stanley raises target price to $9.00 from $6.00

* Fox Corp FOXA.O: Guggenheim raises target price to $45 from $44

* GE Vernova Inc GEV.N: Guggenheim initiates coverage with buy rating; target price $300

* Hanmi Financial Corp HAFC.O: Wedbush cuts target price to $21 from $22

* Hershey HSY.N: Barclays cuts target price to $202 from $204

* Hewlett Packard Enterprise Co HPE.N: Citigroup resumes with neutral rating; target $20

* Home Depot Inc HD.N: Oppenheimer raises target price to $400 from $345

* Hut 8 Corp HUT.O: Needham raises target price to $16.50 from $15

* Ideaya Biosciences Inc IDYA.O: Wedbush cuts target price to $52 from $54

* Insperity Inc NSP.N: William Blair cuts to market perform rating

* Instacart CART.O: Morgan Stanley cuts target price to $41.00 from $45.00

* Invitation Homes Inc INVH.N: BofA Global Research cuts price objective to $37 from $39

* Juniper Networks Inc JNPR.N: Citigroup resumes coverage with neutral rating; target price $40

* Kenvue Inc KVUE.N: Jefferies initiates coverage with buy rating; target price $27

* Kenvue Inc KVUE.N: RBC cuts to sector perform from outperform

* Keurig DR Pepper Inc. KDP.O: Wells Fargo raises target price to $43 from $41

* Keycorp KEY.N: Wedbush raises target price to $18 from $17

* Kimberly-Clark Corporation KMB.N: Wells Fargo raises target price to $140 from $134

* Lamb Weston Holdings Inc LW.N: TD Cowen raises target price to $65 from $61

* Lennar Corp LEN.N: Citigroup raises target price to $196 from $164

* Leonardo DRS Inc DRS.O: BofA Global Research raises price objective to $30 from $26

* Light & Wonder Inc LNW.O: JP Morgan cuts target price to $103 from $111

* Lipocine Inc LPCN.O: Alliance Global Partners initiates with buy rating; target $10

* Lowe's Companies Inc LOW.N: Oppenheimer raises target price to $305 from $230

* Lowe's Companies Inc LOW.N: Oppenheimer raises to outperform from perform

* Lowe's Cos. LOW.N: Oppenheimer raises target price to $305 from $230

* Lowe's Cos. LOW.N: Oppenheimer raises to outperform from perform

* Lyft Inc LYFT.O: Raymond James resumes coverage with market perform rating

* M&T Bank Corp MTB.N: Wedbush raises target price to $210 from $208

* Maplebear Inc CART.O: Raymond James initiates coverage with market perform rating

* McKesson Corp MCK.N: Baird cuts target price to $531 from $603

* McKesson Corp MCK.N: Baird cuts to neutral

* Modine Manufacturing Co MOD.N: D.A. Davidson raises target price to $155 from $140

* Molson Coors Beverage Company TAP.N: Wells Fargo cuts target price to $52 from $54

* Mosaic Co MOS.N: Wells Fargo cuts target price to $27 from $29

* National Health Investors NHI.N: BofA Global Research initiates with buy rating

* National Health Investors NHI.N: BofA Global Research initiates with price objective $92

* Newell Brands Inc. NWL.O: Wells Fargo cuts target price to $8 from $9

* Okta Inc OKTA.O: Jefferies cuts target price to $85 from $100

* P&G PG.N: Piper Sandler initiates coverage with neutral rating; target price $174

* Pacific Premier Bancorp Inc PPBI.O: Wedbush cuts target price to $27 from $28

* Pacira Biosciences Inc PCRX.O: Jefferies raises target price to $18 from $15

* Pfizer PFE.N: Guggenheim raises target price to $36 from $35

* Pinterest PINS.N: Oppenheimer initiates coverage With Outperform rating; target $45

* Prestige Consumer Healthcare PBH.N: Jefferies assumes with hold vs buy rating; PT $76 vs $70

* Procore Technologies PCOR.N: Baird initiates coverage with outperform rating; PT $73

* Prosperity Bancshares Inc PB.N: Wedbush raises target price to $90 from $75

* Prosperity Bancshares Inc PB.N: Wedbush raises to outperform from neutral

* Protagonist Therapeutics Inc PTGX.O: TD Cowen initiates coverage with buy rating; PT $65

* Public Service Enterprise Group Inc PEG.N: UBS raises target price to $94 from $87

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts target price to $1077 from $1175

* Regeneron Pharmaceuticals Inc REGN.O: Leerink Partners cuts to market perform from outperform

* Regeneron Pharmaceuticals Inc REGN.O: RBC cuts target price to $1,252 from $1,282

* Regions Financial RF.N: Wedbush raises target price to $28 from $23

* Regions Financial RF.N: Wedbush raises to outperform from neutral

* Reinsurance Group of America Inc RGA.N: Raymond James raises target to $250 from $228

* Replimune Group Inc REPL.O: JP Morgan raises target price to $17 from $14

* Ryan Specialty Holdings Inc RYAN.N: BMO raises target price to $75 from $65

* Ryan Specialty Holdings Inc RYAN.N: BMO raises to outperform from market perform

* Sable Offshore Corp SOC.N: Benchmark raises target price to $37 from $24

* Salesforce Inc CRM.N: Piper Sandler raises target price to $325 from $268

* Salesforce Inc CRM.N: Piper Sandler raises to overweight from neutral

* Sallie Mae SLM.O: Wedbush cuts target price to $26 from $29

* Shake Shack Inc SHAK.N: JP Morgan cuts target price to $102 from $105

* Sharkninja Inc SN.N: Canaccord Genuity raises target price to $126 from $105

* Sirius XM Holdings Inc SIRI.O: Morgan Stanley resumes with underweight rating; PT $23

* Snowflake Inc SNOW.N: UBS cuts target price to $125 from $155

* Spectrum Brands Holdings, Inc. SPB.N: Wells Fargo raises target price to $95 from $90

* Starbucks SBUX.O: Jefferies cuts target price to $76 from $80

* Starbucks SBUX.O: Jefferies cuts to underperform from hold

* Talen Energy Corp. TLN.O: Oppenheimer raises target price to $210 from $167

* Texas Capital Bancshares Inc TCBI.O: Wedbush raises target price to $77 from $70

* the Clorox Company CLX.N: Wells Fargo raises target price to $155 from $135

* the Estee Lauder Companies Inc. EL.N: Wells Fargo cuts target price to $105 from $117

* Tradeweb Markets Inc TW.O: Jefferies raises target price to $118 from $109

* Tripadvisor Inc TRIP.O: Citigroup cuts target price to $16 from $20

* Triumph Group Inc TGI.N: BofA Global Research cuts to underperform from buy

* Triumph Group Inc TGI.N: BofA Global Research cuts price objective to $12 from $17

* Uber UBER.N: Raymond James resumes coverage with strong buy rating; price target $90

* Union Pacific Corp UNP.N: BofA Global Research cuts price objective to $270 from $273

* Valley National Bancorp VLY.O: Wedbush raises target price to $10 from $9

* Verizon VZ.N: Raymond James raises target price to $48 from $44

* Vistra Corp VST.N: Jefferies raises target price to $137 from $99

* Walmart WMT.N: Truist Securities raises target price to $89 from $76

* Walmart WMT.N: Truist Securities raises to buy from hold

* Western Alliance Bancorp WAL.N: Wedbush adds stock to its best ideas list

* Western Alliance Bancorp WAL.N: Wedbush raises target price to $105 from $90

* Zevra Therapeutics Inc ZVRA.O: Canaccord Genuity raises target price to $25 from $22


(Compiled by Bengaluru Newsroom)

</body></html>

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.